UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies

Annals of oncology, 2017-11, Vol.28 (11), p.2860-2865

2017

Volltextzugriff (PDF)

Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?

Annals of oncology, 2021-07, Vol.32 (7), p.936-937

2021

Volltextzugriff (PDF)

Association between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1

Annals of oncology, 2018-10, Vol.29, p.viii405-viii405

2018

Volltextzugriff (PDF)

Incidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy

Annals of oncology, 2018-10, Vol.29, p.viii428-viii429

2018

Volltextzugriff (PDF)

Evaluating immunotherapy-related adverse events reporting in the French national hospital discharge database (PMSI): a pilot study

Revue d'épidémiologie et de santé publique, 2023-03, Vol.71

2023

Volltextzugriff (PDF)

1627TiP Impact of patient education on immune-related adverse events (irAEs) during immune checkpoint inhibitor (ICI)

Annals of oncology, 2022-09, Vol.33, p.S1285

2022

Volltextzugriff (PDF)

1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma

Annals of oncology, 2022-09, Vol.33, p.S1302-S1303

2022

Volltextzugriff (PDF)

984P Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)

Annals of oncology, 2021-09, Vol.32, p.S842-S843

2021

Volltextzugriff (PDF)

1732MO Pembrolizumab and nintedanib for patients with advanced mesothelioma

Annals of oncology, 2021-09, Vol.32, p.S1198-S1198

2021

Volltextzugriff (PDF)

156TiP Impact of neoadjuvant immunotherapy in early stage breast cancer before standard therapy (BIS-Program)

ESMO open, 2023-05, Vol.8 (1), p.101495, Article 101495

2023

Volltextzugriff (PDF)

Étude de la tolérance et de l’efficacité des immune checkpoints inhibiteurs en oncologie chez les patients atteints d’une maladie auto-immune ou inflammatoire

La revue de medecine interne, 2016-12, Vol.37, p.A116-A117

2016

Volltextzugriff (PDF)

P315 Gastrointestinal immune related adverse events associated with programmed-Death 1 blockade

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S237-S237

2017

Volltextzugriff (PDF)

Evaluating immunotherapy-related adverse events reporting in the French national hospital discharge database (PMSI): a pilot study

Revue d'épidémiologie et de santé publique, 2023-03, Vol.71, p.101528, Article 101528

2023

Volltextzugriff (PDF)

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies

Annals of oncology, 2017-11, Vol.28 (11), p.2860

2017

Volltextzugriff (PDF)

Télémaque: Archiver et interpréter les témoignages autobiographiques

Albert Mingelgrün, Beatrice Barbalato (dir.)

2012

Volltextzugriff (PDF)

1141PDAssociation between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1206PIncidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

Journal of hepatology, 2018-06, Vol.68 (6), p.1181-1190

2018

Volltextzugriff (PDF)

Bioactivité des extraits foliaires de Ruta Chalepensis l. (rutaceae) sur la mortalité des larves de Culiseta Longiareolata (diptera, culicidae)

Lebanese science journal, 2019-04, Vol.20 (1), p.1-9

2019

Volltextzugriff (PDF)

Mes flocons: Entretien (novembre 2023)

Textyles : revue des lettres belges de langue française, 2023-12 (64), p.121-130

2023

Volltextzugriff (PDF)

Mes flocons

Textyles : revue des lettres belges de langue française, 2023-12, p.121-130

2023

Volltextzugriff (PDF)

Early alterations of the neuronal network processing whisker‐related sensory signal during absence epileptogenesis

Epilepsia (Copenhagen), 2022-02, Vol.63 (2), p.497-509

2022

Volltextzugriff (PDF)

Michel Butor, créateur autopoïétique

Loxias, 2018-03, Vol.60

Laghouati, Sofiane

2018

Volltextzugriff (PDF)

Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies

European journal of cancer (1990), 2020-04, Vol.129, p.71-79

2020

Volltextzugriff (PDF)

Barrel cortex development lacks a key stage of hyperconnectivity from deep to superficial layers in a rat model of Absence Epilepsy

Progress in neurobiology, 2024-03, Vol.234, p.102564-102564, Article 102564

2024

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Humans
(12)
Oncology
(12)
Immunotherapy
(11)
Life Sciences
(9)
Male
(8)
Adult
(7)
Female
(7)
Aged
(6)
Cancer
(6)
Middle Aged
(6)
Prospective Studies
(6)
Tumors
(6)
Aged, 80 And Over
(5)
Immunotherapy - Adverse Effects
(5)
Patients
(5)
Adolescent
(4)
Antineoplastic Agents, Immunological - Adverse Effects
(4)
Monoclonal Antibodies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies

Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?

Association between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1

Incidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy

Evaluating immunotherapy-related adverse events reporting in the French national hospital discharge database (PMSI): a pilot study

1627TiP Impact of patient education on immune-related adverse events (irAEs) during immune checkpoint inhibitor (ICI)

1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma

984P Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)

1732MO Pembrolizumab and nintedanib for patients with advanced mesothelioma

156TiP Impact of neoadjuvant immunotherapy in early stage breast cancer before standard therapy (BIS-Program)

Étude de la tolérance et de l’efficacité des immune checkpoints inhibiteurs en oncologie chez les patients atteints d’une maladie auto-immune ou inflammatoire

P315 Gastrointestinal immune related adverse events associated with programmed-Death 1 blockade

Evaluating immunotherapy-related adverse events reporting in the French national hospital discharge database (PMSI): a pilot study

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies

Télémaque: Archiver et interpréter les témoignages autobiographiques

1141PDAssociation between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1

1206PIncidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

Bioactivité des extraits foliaires de Ruta Chalepensis l. (rutaceae) sur la mortalité des larves de Culiseta Longiareolata (diptera, culicidae)

Mes flocons: Entretien (novembre 2023)

Mes flocons

Early alterations of the neuronal network processing whisker‐related sensory signal during absence epileptogenesis

Michel Butor, créateur autopoïétique

Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies

Barrel cortex development lacks a key stage of hyperconnectivity from deep to superficial layers in a rat model of Absence Epilepsy

Suchergebnisse filtern